Leukemia, Myeloid, Chronic-Phase (CML-CP)
1 clinical trials · Condition
◉ Watch Leukemia, Myeloid, Chronic-Phase (CML-CP)
| Record | Firm | Date |
|---|---|---|
| Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey (NCT01188278) | Bristol-Myers Squibb | 2010-07-01 |
Track Leukemia, Myeloid, Chronic-Phase (CML-CP) automatically
Every clearance here is in the API, with alerts when new ones post.